The Dow Jones closed higher on Wednesday following the release of Fed minutes. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
AIM ImmunoTech
- The Trade: AIM ImmunoTech Inc. (NYSE:AIM) CEO and President Thomas K Equels bought a total of 161,291 shares at an average price of $0.31. To acquire these shares, it cost around $50 thousand.
- What's Happening: AIM ImmunoTech, last month, reported safety, tolerability and biological activity data for intranasal ampligen in healthy subjects.
- What AIM ImmunoTech Does: AIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders, viral and cancer diseases.
Guerrilla RF
- The Trade: Guerrilla RF, Inc. (OTC:GUER) CFO Alen John Berg acquired a total of 20,000 shares at an average price of $1.30. The insider spent around $26 thousand to buy those shares.
- What's Happening: The company's shares fell 6% over the past month.
- What Guerrilla RF Does: Guerrilla RF Inc is a semiconductor company focused on high performance MMICs (monolithic microwave integrated circuits) for the wireless and infrastructure market.
Check This Out: Investor Fear Eases Following Release Of Fed Minutes
InnSuites Hospitality Trust
- The Trade: InnSuites Hospitality Trust (NYSE:IHT) President and CEO James F Wirth acquired a total of 43,478 shares at an average price of $1.61. To acquire these shares, it cost around $70 thousand.
- What's Happening: The company's stock has declined around 40% over the past six months.
- What InnSuites Hospitality Trust Does: InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties.
Don't forget to check out our premarket coverage here
ProtoKinetix
- The Trade: ProtoKinetix, Incorporated (OTC:PKTX) President and CEO Clarence E. Smith acquired a total of 2,187,489 shares at an average price of $0.02. The insider spent $46.87 thousand to buy those shares.
- What's Happening: ProtoKinetix shares have tumbled 62% over the previous year.
- What ProtoKinetix Does: ProtoKinetix Inc is a research and development stage biotechnology company focused on scientific medical research of AFGPs (Anti-Freeze Glycoproteins).
週三,在美聯儲會議紀要發佈後,道瓊恩斯指數收盤走高。與此同時,投資者關注的是一些值得注意的內幕交易。
當內部人士買賣股票時,這表明了他們對公司前景的信心或擔憂。對細價股感興趣的投資者和交易員可以在他們的整體投資或交易決策中考慮這一因素。
以下是最近幾筆值得注意的細價股內幕交易。欲瞭解更多資訊,請查看Benzinga的內幕交易站臺。
目標免疫技術
- 行業:AIM免疫科技公司。(紐約證券交易所股票代碼:AIM)首席執行官兼總裁託馬斯·K·埃克斯共買入161,291股平均價格為0.31美元。收購這些股份的成本約為5萬美元。
- 正在發生的事情:目的免疫科技上個月報道了健康受試者鼻內注射Ampligen的安全性、耐受性和生物活性數據。
- AIM免疫科技的用途:目的免疫科技公司是一家免疫製藥公司,專注於研究和開發治療免疫疾病、病毒和癌症的療法。
遊擊隊射頻
- 《貿易》:遊擊隊射頻公司。(場外交易:Guer)首席財務官Alen John Berg共收購2萬股平均價格為1.30美元。這位內部人士花了大約2.6萬美元購買了這些股票。
- 發生了什麼事?在過去的一個月裡,該公司的股價下跌了6%。
- 遊擊隊的射頻能做什麼:Guerrilla RF Inc.是一家專注於為無線和基礎設施市場提供高性能MMIC(單片微波積體電路)的半導體公司。
看看這個:美聯儲會議紀要發佈後,投資者的擔憂有所緩解
InnSuite酒店信託
- 《貿易》:InnSuite酒店信託(紐約證券交易所代碼:IHT)總裁和首席執行官詹姆斯·F·沃斯共收購43,478股均價為1.61美元。收購這些股份的成本約為7萬美元。
- 發生了什麼事?:在過去的六個月裡,該公司的股票下跌了約40%。
- InnSuite酒店信託公司的業務:InnSuites Hotality Trust是一家房地產投資信託基金。它從事酒店物業的所有權和運營。
別忘了在這裡查看我們的售前報道
原動能管
- 《貿易》:ProtoKinetix公司(場外交易代碼:PKTX)總裁和首席執行官克拉倫斯·E·史密斯共購入2187,489股平均價格為0.02美元。這位內部人士花了468.7萬美元購買了這些股票。
- 發生了什麼事?:ProtoKinetix的股價比前一年下跌了62%。
- ProtoKinetix的用途:ProtoKinetix Inc是一家研發階段的生物技術公司,專注於AFGP(抗凍糖蛋白)的科學醫學研究。